Iveric Bio announces FDA approval for IZERVAY™️️

Iveric Bio announces FDA approval for IZERVAY™️️

Iveric Bio announces FDA approval for IZERVAY™️️

Congratulations to Iveric Bio for their FDA approval for IZERVAY™️️, a new treatment for Geographic Atrophy (GA). Modality Solutions is proud to have been a part of its cold chain strategy!

Read the full press release here.

View all blogs

Stay on top of the industry trends